NASDAQ · TWST
Twist Bioscience Corporation
$173.45$0.00 (0.0%)
Twist Bioscience Corporation’s quoted price sits in the upper half of its reported 52-week range, 21.06% below the high.
Loading market information…
OTC · FUNR · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Funr’s quoted price sits in the lower half of its reported 52-week range, 100.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
FUNR is focused on the development of proprietary BioTech, MedTech, Statistical Data Gathering combined with AI technology. The Company concentrates on intellectual property/brand licensing with the goal of several divisions under the FUNR community and umbrella. The company was formerly known as Cuba Beverage Company and changed its name to FUNR in October 2022.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:18 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$173.45$0.00 (0.0%)
Twist Bioscience Corporation’s quoted price sits in the upper half of its reported 52-week range, 21.06% below the high.
$72.71+$0.02 (+0.03%)
Bio-Techne Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.05% below the high.
$384.40-$0.72 (-0.19%)
Bio-Rad Laboratories, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.99% below the high.
$36.14+$0.69 (+1.95%)
Caris Life Sciences, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.99% below the high.
$11.75-$0.18 (-1.51%)
Vir Biotechnology, Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.61% below the high.
$17.85-$0.10 (-0.56%)
ADARx Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 23.09% below the high.
$20.91+$0.26 (+1.26%)
Vor Biopharma Inc.’s quoted price sits in the upper half of its reported 52-week range, 21.86% below the high.
$0.66$0.00 (0.0%)
Glorywin Entertainment Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 83.15% below the high.
